28-Year-Old Woman with Hyperprolactinemia and Its Relationship to Polycystic Ovary Syndrome

    November 2023 in “ Manuju
    Ely Malihah, Diana Novitasari, A. R. Nasution, Mietha Apriyanti
    Image of study
    TLDR Treating hyperprolactinemia can help manage PCOS symptoms.
    This document discusses a 28-year-old woman with hyperprolactinemia and its relationship to Polycystic Ovary Syndrome (PCOS). PCOS is characterized by hyperandrogenism, menstrual irregularities, and ovarian cysts, and is often linked with hyperinsulinemia and insulin resistance. Symptoms include enlarged ovaries, irregular menstrual cycles, low back pain, hirsutism, alopecia, acne, and skin tags. Laboratory tests are essential to rule out other diagnoses and measure androgen levels. After treatment with bromocriptine, the patient's prolactin levels decreased, highlighting the importance of considering hyperprolactinemia in PCOS cases.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 7 results

      community does lowering your prolactin levels regrow hair?

      in Research/Science  11 upvotes 2 years ago
      The potential of lowering prolactin levels to regrow hair, with a reference to Bayer's drug HMI 115 which has been indicated as having this effect. Treatments mentioned include Minoxidil and Finasteride, as well as RU58841.

      community how about progesterone cream?

      in Research/Science  23 upvotes 9 months ago
      Progesterone cream might help with hair loss by inhibiting DHT production and suppressing prolactin, which can increase DHT. Some dermatologists have used progesterone for hair loss treatment, and it has been effective, sometimes combined with minoxidil, finasteride, and hydrocortisone.

      community hmi115 is coming. Prepare yourselves for what's coming

      in Technology  108 upvotes 1 year ago
      The conversation discusses HMI-115, a potential cure for hair loss. Users share mixed opinions, with some expressing skepticism and others sharing anecdotal evidence of its effectiveness, including photos of significant hair regrowth from a trial participant.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  39 upvotes 2 years ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

    Related Research

    5 / 5 results